Home
>
US Stocks
>
Macrogenics Inc
Macrogenics Inc
MGNX

Macrogenics Inc (MGNX)

$19.3914.66%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
19.44
Today Low/High
19.12 / 19.54
52 Week Low/High
$18.16 / $36.48
Market Cap
$1.46B

Company Details

MacroGenics is a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. The combination of MacroGenics' technology platforms and protein engineering expertise has allowed the Company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. MacroGenics and the MacroGenics logo are trademarks or registered trademarks of MacroGenics, Inc.
Organisation
Macrogenics Inc
Headquaters
Rockville, Maryland, US
Employees
370
Industry
Health Technology
CEO
Scott Koenig

Discover more

Frequently Asked Questions

What is Macrogenics Inc (MGNX) share price today?

Can Indians buy Macrogenics Inc (MGNX) shares?

How can I buy Macrogenics Inc (MGNX) shares from India?

Can Fractional shares of Macrogenics Inc (MGNX) be purchased?

What are the documents required to start investing in Macrogenics Inc (MGNX) stocks?

We are a SEBI registered investement advisor